Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumors
A, Kunert, M, Chmielewski, R, Wijers, C, Berrevoets, H, Abken, R, DebetsLanguage:
english
Journal:
OncoImmunology
DOI:
10.1080/2162402x.2017.1378842
Date:
September, 2017
File:
PDF, 3.25 MB
english, 2017